Page 4 - Neumora Therapeutics Company Profile News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Neumora therapeutics company profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Neumora Therapeutics Company Profile Today - Breaking & Trending Today

Neumora Therapeutics, Inc. (NASDAQ:NMRA) Given Consensus Recommendation of "N/A" by Brokerages

Shares of Neumora Therapeutics, Inc. (NASDAQ:NMRA – Get Free Report) have received a consensus rating of “N/A” from the zero research firms that are covering the stock, MarketBeat Ratings reports. NMRA has been the subject of a number of research reports. Royal Bank of Canada assumed coverage on Neumora Therapeutics in a research note on […] ....

William Blair , Stifel Nicolaus , Neumora Therapeutics Inc , Arch Venture Partners Xii Llc , Royal Bank , Neumora Therapeutics Company Profile , Jpmorgan Chase Co , Amgen Inc , Neumora Therapeutics , Get Free Report , Marketbeat Ratings , Therapeutics Trading Down , Arch Venture Partners Xii , Get Free , Neumora Therapeutics Daily , Nasdaq Nmra ,

Neumora Therapeutics (NASDAQ:NMRA) Earns Overweight Rating from Analysts at JPMorgan Chase & Co.

JPMorgan Chase & Co. started coverage on shares of Neumora Therapeutics (NASDAQ:NMRA – Get Free Report) in a research report issued to clients and investors on Tuesday, Marketbeat Ratings reports. The firm set an “overweight” rating and a $21.00 price target on the stock. JPMorgan Chase & Co.‘s target price points to a potential upside […] ....

United States , Stifel Nicolaus , William Blair , Kristina Burow , Jpmorgan Chase Co , Neumora Therapeutics Inc , Amgen Inc , Securities Exchange Commission , Royal Bank , Neumora Therapeutics Company Profile , Neumora Therapeutics , Get Free Report , Marketbeat Ratings , Therapeutics Trading Down , Director Kristina Burow , Exchange Commission , Neumora Therapeutics Daily , Nasdaq Nmra , Initiated Coverage , Jpmorgan Chase Co ,

Insider Buying: Neumora Therapeutics, Inc. (NASDAQ:NMRA) Major Shareholder Acquires 24,504 Shares of Stock

Neumora Therapeutics, Inc. (NASDAQ:NMRA – Get Free Report) major shareholder Arch Venture Partners Xii, Llc purchased 24,504 shares of the business’s stock in a transaction on Wednesday, September 27th. The stock was acquired at an average price of $12.31 per share, for a total transaction of $301,644.24. Following the completion of the purchase, the insider […] ....

Arch Venture Partners Xii Llc , Securities Exchange Commission , Neumora Therapeutics Company Profile , Neumora Therapeutics Inc , Neumora Therapeutics , Get Free Report , Arch Venture Partners Xii , Exchange Commission , Venture Partners Xii , Neumora Therapeutics Daily , Nasdaq Nmra , Insider Trading , Nsider Trades ,

Neumora Therapeutics (NASDAQ:NMRA) Trading Down 4.8%

Neumora Therapeutics, Inc. (NASDAQ:NMRA – Get Free Report)’s stock price traded down 4.8% on Monday . The stock traded as low as $10.50 and last traded at $10.50. 124,789 shares changed hands during mid-day trading, a decline of 85% from the average session volume of 849,751 shares. The stock had previously closed at $11.03. Neumora […] ....

Kristina Burow , Neumora Therapeutics Inc , Neumora Therapeutics Company Profile , Amgen Inc , Neumora Therapeutics , Get Free Report , Director Kristina Burow , Neumora Therapeutics Daily , Nasdaq Nmra ,

Neumora Therapeutics, Inc. (NASDAQ:NMRA) Major Shareholder Buys $681,502.80 in Stock

Neumora Therapeutics, Inc. (NASDAQ:NMRA – Get Free Report) major shareholder Arch Venture Partners Xii, Llc purchased 60,740 shares of the company’s stock in a transaction that occurred on Monday, September 25th. The shares were purchased at an average cost of $11.22 per share, for a total transaction of $681,502.80. Following the completion of the transaction, […] ....

Neumora Therapeutics Company Profile , Neumora Therapeutics Inc , Securities Exchange Commission , Arch Venture Partners Xii Llc , Neumora Therapeutics , Get Free Report , Arch Venture Partners Xii , Exchange Commission , Venture Partners Xii , Neumora Therapeutics Daily , Nasdaq Nmra , Insider Trading , Nsider Trades ,